Michael Cher
Michael Cher
Professor of Urology, Wayne State University
Verified email at med.wayne.edu
Title
Cited by
Cited by
Year
Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
ML Cher, GS Bova, DH Moore, EJ Small, PR Carroll, SS Pin, JI Epstein, ...
Cancer research 56 (13), 3091-3102, 1996
4911996
Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy
ML CHER, FJ BIANCO, JS LAM, LP DAVIS, DJ GRIGNON, WA SAKR, ...
The Journal of urology 160 (4), 1387-1391, 1998
3111998
CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: the role of bone microenvironment‐associated CXCL12
SR Chinni, S Sivalogan, Z Dong, JCT Filho, X Deng, RD Bonfil, ML Cher
The Prostate 66 (1), 32-48, 2006
2722006
Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone
JA Nemeth, JF Harb, U Barroso, Z He, DJ Grignon, ML Cher
Cancer research 59 (8), 1987-1993, 1999
2701999
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis
JA Nemeth, R Yousif, M Herzog, M Che, J Upadhyay, B Shekarriz, ...
Journal of the National Cancer Institute 94 (1), 17-25, 2002
2652002
Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer
ML Cher, D Macgrogan, R Bookstein, JA Brown, RB Jenkins, RH Jensen
Genes, Chromosomes and Cancer 11 (3), 153-162, 1994
2571994
Prostate cancer: the use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy
JS Wolf, M Cher, M Dall'Era, JC Presti, H Hricak, PR Carroll
The Journal of urology 153 (3S), 993-999, 1995
2351995
Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM
D Kong, E Heath, W Chen, ML Cher, I Powell, L Heilbrun, Y Li, S Ali, ...
PloS one 7 (3), e33729, 2012
2062012
Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment
BF Sloane, S Yan, I Podgorski, BE Linebaugh, ML Cher, J Mai, ...
Seminars in cancer biology 15 (2), 149-157, 2005
1852005
Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis
ML Cher, HR Biliran, S Bhagat, Y Meng, M Che, J Lockett, J Abrams, ...
Proceedings of the National Academy of Sciences 100 (13), 7847-7852, 2003
1852003
Lycopene and soy isoflavones in the treatment of prostate cancer
U Vaishampayan, M Hussain, M Banerjee, S Seren, FH Sarkar, J Fontana, ...
Nutrition and cancer 59 (1), 1-7, 2007
1792007
Platelet‐derived growth factor‐D overexpression contributes to epithelial‐mesenchymal transition of PC3 prostate cancer cells
D Kong, Z Wang, SH Sarkar, Y Li, S Banerjee, A Saliganan, HRC Kim, ...
Stem Cells 26 (6), 1425-1435, 2008
1712008
Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1 …
M Toth, MM Bernardo, DC Gervasi, PD Soloway, Z Wang, HF Bigg, ...
Journal of Biological Chemistry 275 (52), 41415-41423, 2000
1602000
CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone
SR Chinni, H Yamamoto, Z Dong, A Sabbota, RD Bonfil, ML Cher
Molecular Cancer Research 6 (3), 446-457, 2008
1482008
Circulating tumor cells: finding the needle in the haystack
X Zhe, ML Cher, RD Bonfil
American journal of cancer research 1 (6), 740, 2011
1452011
Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer
EL Gheiler, MV Tefilli, R Tiguert, D Grignon, ML Cher, W Sakr, JE Pontes, ...
Urology 51 (5), 789-795, 1998
1391998
Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand …
Y Li, O Kucuk, M Hussain, J Abrams, ML Cher, FH Sarkar
Cancer research 66 (9), 4816-4825, 2006
1372006
PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
MK Conley-LaComb, A Saliganan, P Kandagatla, YQ Chen, ML Cher, ...
Molecular cancer 12 (1), 1-10, 2013
1252013
Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue
Z Dong, RD Bonfil, S Chinni, X Deng, JC Trindade Filho, M Bernardo, ...
The American journal of pathology 166 (4), 1173-1186, 2005
1232005
Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein
Y Li, M Che, S Bhagat, KL Ellis, O Kucuk, DR Doerge, J Abrams, ML Cher, ...
Neoplasia 6 (4), 354-363, 2004
1192004
The system can't perform the operation now. Try again later.
Articles 1–20